Risk Clinical Trials

541 recruitingLast updated: May 11, 2026

There are 541 actively recruiting risk clinical trials across 72 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Risk Trials at a Glance

541 actively recruiting trials for risk are listed on ClinicalTrialsFinder across 6 cities in 72 countries. The largest study group is Not Applicable with 214 trials, with the heaviest enrollment activity in New York, Boston, and Houston. Lead sponsors running risk studies include M.D. Anderson Cancer Center, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Ohio State University.

Treatments under study

About Risk Clinical Trials

Looking for clinical trials for Risk? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 541 trials

Recruiting
Not Applicable

Coronary Artery Disease Assessment Strategies in TAVI Patients

Coronary Artery DiseaseTranscatheter Aortic Valve ReplacementHeart Disease Risk Factors
Insel Gruppe AG, University Hospital Bern546 enrolled1 locationNCT06559332
Recruiting
Phase 2

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

HPV InfectionASC-USUterine Cervical Dysplasia+3 more
Amplexd Therapeutics, Inc.45 enrolled1 locationNCT07572396
Recruiting
Not Applicable

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

Cardiometabolic Risk Factors in Adult Wheelchair Users
University of Alabama at Birmingham132 enrolled1 locationNCT05606432
Recruiting
Phase 3

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals454 enrolled94 locationsNCT06510374
Recruiting
Not Applicable

WORTH Paths Intervention

Sexual and Reproductive HealthSubstance Use Disorder (SUD)Sexual Risk Behavior
Fairleigh Dickinson University50 enrolled1 locationNCT06889831
Recruiting
Not Applicable

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Cardiovascular DiseasesCardiometabolic Risk FactorsCognition+2 more
Loughborough University16 enrolled1 locationNCT06953232
Recruiting
Phase 1

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

Acute Myeloid LeukemiaR/R AMLR/R HR-MDS+1 more
Genmab78 enrolled9 locationsNCT07384715
Recruiting
Phase 4

LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery

myocardial injury after non-cardiac surgeryAutonomic DysfunctionCardiovascular (CV) Risk+3 more
Insel Gruppe AG, University Hospital Bern114 enrolled1 locationNCT07168421
Recruiting

Dual-Task Effects on Gait and Balance in MCRS

BalanceGaitMotoric Cognitive Risk Syndrome+1 more
Balikesir University35 enrolled1 locationNCT07572968
Recruiting

Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Cirrhosis, LiverDiabetes Mellitus RiskTransplant-Related Disorder+1 more
University of Chicago60 enrolled1 locationNCT06950788
Recruiting

Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

Motoric Cognitive Risk SyndromeCognitive-Motor InteractionSensorimotor Performance
Balikesir University35 enrolled1 locationNCT07572942
Recruiting

Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women

Cardiovascular (CV) Risk
National Heart, Lung, and Blood Institute (NHLBI)250 enrolled1 locationNCT04014348
Recruiting

Digital Strategies to Advance Help-Seeking Aim 1 and 2

Early PsychosisFirst-episode PsychosisClinical High Risk
Columbia University25,000 enrolled1 locationNCT06774430
Recruiting
Not Applicable

Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer

High-risk Prostate Cancer
Center Eugene Marquis390 enrolled1 locationNCT07189598
Recruiting

Imaging Techniques in MRI

HealthyHealthy VolunteersCardiac Risk Factors
National Institutes of Health Clinical Center (CC)1,000 enrolled1 locationNCT01130545
Recruiting
Phase 4

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

Type 1 DiabetesPregnancy, High Risk
Ohio State University44 enrolled1 locationNCT07293715
Recruiting
Phase 2Phase 3

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

High Risk Neuroblastoma
Renaissance Pharma Ltd.144 enrolled2 locationsNCT07549321
Recruiting
Not Applicable

The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities

cognitive healthPreventionDementia Risk Factors
University of Coimbra100 enrolled1 locationNCT06922071
Recruiting
Not Applicable

The SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTervention for Cardiometabolic Health) Trial

Metabolic HealthHypertensionDiabetes Mellitus, Type 2+3 more
University of Toronto300 enrolled1 locationNCT06907862
Recruiting
Not Applicable

ALERT-ED: Awareness and Linkage to Resources for At-Risk Emergency Department Patients

High Fall Risk
University of Colorado, Denver20,700 enrolled1 locationNCT07028463